Venker Eric
CIK 1801917
Transactions on file
92
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-10-22 | 2026-10-20 | ROIV Roivant Sciences Ltd. | Officer President & Immunovant CEO | Sale | 14,144 | $501.0K | +3.0% | open → |
| 2026-10-22 | 2026-10-20 | ROIV Roivant Sciences Ltd. | Officer President & Immunovant CEO | Sale | 185,856 | $6.52M | +4.0% | open → |
| 2026-10-05 | 2026-10-02 | IMVT Immunovant, Inc. | OfficerDirector Chief Executive Officer | Sale | 3,506 | $119.6K | -16.7% | open → |
| 2026-10-05 | 2026-10-01 | IMVT Immunovant, Inc. | OfficerDirector Chief Executive Officer | Disp. | 85,886 | $2.89M | -15.6% | open → |
| 2026-10-05 | 2026-10-01 | IMVT Immunovant, Inc. | OfficerDirector Chief Executive Officer | Exer. | 92,187 | $1.33M | +96.5% | open → |
| 2026-10-02 | 2026-09-30 | ROIV Roivant Sciences Ltd. | Officer President & Immunovant CEO | Sale | 200,000 | $7.32M | -0.4% | open → |
| 2026-10-02 | 2026-09-30 | ROIV Roivant Sciences Ltd. | Officer President & Immunovant CEO | Exer. | 200,000 | $770.0K | +847.8% | open → |
| 2026-09-02 | 2026-08-28 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Sale | 33,818 | $1.23M | +0.1% | open → |
| 2026-09-02 | 2026-08-28 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Sale | 166,182 | $5.92M | +2.4% | open → |
| 2026-09-02 | 2026-08-28 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Exer. | 200,000 | $770.0K | +847.8% | open → |
| 2026-08-25 | 2026-08-20 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Tax | 13,909 | $512.4K | -1.0% | open → |
| 2026-07-30 | 2026-07-27 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Sale | 200,000 | $6.99M | +4.4% | open → |
| 2026-07-30 | 2026-07-27 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Exer. | 200,000 | $770.0K | +847.8% | open → |
| 2026-07-06 | 2026-07-02 | IMVT Immunovant, Inc. | OfficerDirector Chief Executive Officer | Sale | 3,092 | $119.0K | -26.2% | open → |
| 2026-07-06 | 2026-07-01 | IMVT Immunovant, Inc. | OfficerDirector Chief Executive Officer | Disp. | 86,629 | $3.30M | -25.5% | open → |
| 2026-07-06 | 2026-07-01 | IMVT Immunovant, Inc. | OfficerDirector Chief Executive Officer | Exer. | 92,188 | $1.33M | +96.5% | open → |
| 2026-06-26 | 2026-06-24 | ROIV Roivant Sciences Ltd. | Officer President & Immunovant CEO | Sale | 46,234 | $1.55M | +8.9% | open → |
| 2026-06-26 | 2026-06-24 | ROIV Roivant Sciences Ltd. | Officer President & Immunovant CEO | Sale | 153,766 | $5.08M | +10.4% | open → |
| 2026-06-26 | 2026-06-24 | ROIV Roivant Sciences Ltd. | Officer President & Immunovant CEO | Exer. | 200,000 | $770.0K | +847.8% | open → |
| 2026-05-22 | 2026-05-22 | ROIV Roivant Sciences Ltd. | Officer President & Immunovant CEO | Sale | 200,000 | $6.05M | +20.5% | open → |
| 2026-05-22 | 2026-05-22 | ROIV Roivant Sciences Ltd. | Officer President & Immunovant CEO | Exer. | 200,000 | $770.0K | +847.8% | open → |
| 2026-05-22 | 2026-05-20 | ROIV Roivant Sciences Ltd. | Officer President & Immunovant CEO | Tax | 34,483 | $1.12M | +12.6% | open → |
| 2026-04-09 | 2026-04-07 | IMVT Immunovant, Inc. | OfficerDirector Chief Executive Officer | Grant | 232,252 | $0.00 | — | open → |
| 2026-04-22 | 2026-04-20 | ROIV Roivant Sciences Ltd. | Officer President & Immunovant CEO | Sale | 200,000 | $5.92M | +23.3% | open → |
| 2026-04-22 | 2026-04-20 | ROIV Roivant Sciences Ltd. | Officer President & Immunovant CEO | Exer. | 200,000 | $770.0K | +847.8% | open → |
| 2025-01-22 | 2025-01-21 | ROIV Roivant Sciences Ltd. | Officer President & COO | Exer. | 100,000 | $385.0K | +847.8% | open → |
| 2025-01-22 | 2025-01-21 | ROIV Roivant Sciences Ltd. | Officer President & COO | Sale | 100,000 | $1.13M | +223.5% | open → |
| 2025-01-22 | 2025-01-20 | ROIV Roivant Sciences Ltd. | Officer President & COO | Tax | 8,682 | $96.8K | +227.3% | open → |
| 2025-02-14 | 2025-02-12 | ROIV Roivant Sciences Ltd. | Officer President & COO | Sale | 217,384 | $2.29M | +246.5% | open → |
| 2025-02-14 | 2025-02-12 | ROIV Roivant Sciences Ltd. | Officer President & COO | Exer. | 300,000 | $1.16M | +847.8% | open → |
| 2025-02-14 | 2025-02-13 | ROIV Roivant Sciences Ltd. | Officer President & COO | Exer. | 300,000 | $1.16M | +847.8% | open → |
| 2025-02-14 | 2025-02-13 | ROIV Roivant Sciences Ltd. | Officer President & COO | Sale | 218,041 | $2.27M | +250.2% | open → |
| 2025-02-24 | 2025-02-20 | ROIV Roivant Sciences Ltd. | Officer President & COO | Exer. | 100,000 | $385.0K | +847.8% | open → |
| 2025-02-24 | 2025-02-20 | ROIV Roivant Sciences Ltd. | Officer President & COO | Sale | 100,000 | $1.06M | +242.6% | open → |
| 2025-02-24 | 2025-02-20 | ROIV Roivant Sciences Ltd. | Officer President & COO | Tax | 10,945 | $117.3K | +240.4% | open → |
| 2025-03-24 | 2025-03-24 | ROIV Roivant Sciences Ltd. | Officer President & COO | Sale | 434,478 | $4.70M | +237.2% | open → |
| 2025-03-24 | 2025-03-24 | ROIV Roivant Sciences Ltd. | Officer President & COO | Exer. | 602,311 | $2.32M | +847.8% | open → |
| 2025-03-24 | 2025-03-20 | ROIV Roivant Sciences Ltd. | Officer President & COO | Sale | 315,522 | $3.49M | +229.9% | open → |
| 2025-03-24 | 2025-03-20 | ROIV Roivant Sciences Ltd. | Officer President & COO | Exer. | 400,000 | $1.54M | +847.8% | open → |
| 2025-03-24 | 2025-03-20 | ROIV Roivant Sciences Ltd. | Officer President & COO | Tax | 10,945 | $120.1K | +232.6% | open → |
| 2025-04-22 | 2025-04-20 | ROIV Roivant Sciences Ltd. | Officer President & COO | Tax | 10,945 | $111.1K | +259.5% | open → |
| 2025-04-22 | 2025-04-21 | ROIV Roivant Sciences Ltd. | Officer President & COO | Exer. | 100,000 | $385.0K | +847.8% | open → |
| 2025-04-22 | 2025-04-21 | ROIV Roivant Sciences Ltd. | Officer President & COO | Sale | 100,000 | $1.02M | +257.0% | open → |
| 2025-05-22 | 2025-05-20 | ROIV Roivant Sciences Ltd. | Officer President & COO | Tax | 39,148 | $432.2K | +230.5% | open → |
| 2025-05-22 | 2025-05-20 | ROIV Roivant Sciences Ltd. | Officer President & COO | Sale | 100,000 | $1.09M | +233.2% | open → |
| 2025-05-22 | 2025-05-20 | ROIV Roivant Sciences Ltd. | Officer President & COO | Exer. | 100,000 | $385.0K | +847.8% | open → |
| 2025-06-04 | 2025-06-02 | ROIV Roivant Sciences Ltd. | Officer President & COO | Exer. | 600,000 | $2.31M | +847.8% | open → |
| 2025-06-04 | 2025-06-02 | ROIV Roivant Sciences Ltd. | Officer President & COO | Sale | 433,722 | $4.80M | +229.6% | open → |
| 2025-06-04 | 2025-06-03 | ROIV Roivant Sciences Ltd. | Officer President & COO | Exer. | 785,026 | $3.02M | +847.8% | open → |
| 2025-06-04 | 2025-06-03 | ROIV Roivant Sciences Ltd. | Officer President & COO | Sale | 566,278 | $6.35M | +225.2% | open → |
| 2025-06-24 | 2025-06-20 | ROIV Roivant Sciences Ltd. | Officer President & COO | Sale | 100,000 | $1.15M | +218.7% | open → |
| 2025-06-24 | 2025-06-20 | ROIV Roivant Sciences Ltd. | Officer President & COO | Exer. | 100,000 | $385.0K | +847.8% | open → |
| 2026-02-24 | 2026-02-20 | ROIV Roivant Sciences Ltd. | Officer President & Immunovant CEO | Tax | 7,051 | $191.4K | +34.4% | open → |
| 2025-12-11 | 2025-12-09 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Sale | 200,000 | $4.17M | +75.0% | open → |
| 2025-12-11 | 2025-12-09 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Exer. | 200,000 | $770.0K | +847.8% | open → |
| 2025-11-24 | 2025-11-20 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Tax | 7,051 | $142.9K | +80.0% | open → |
| 2025-11-07 | 2025-11-07 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Sale | 200,000 | $4.04M | +80.5% | open → |
| 2025-11-07 | 2025-11-07 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Exer. | 200,000 | $770.0K | +847.8% | open → |
| 2025-10-17 | 2025-10-17 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Sale | 118,418 | $2.02M | +113.9% | open → |
| 2025-10-17 | 2025-10-17 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Exer. | 118,418 | $1.88M | +130.2% | open → |
| 2025-10-17 | 2025-10-16 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Sale | 318,282 | $5.43M | +114.0% | open → |
| 2025-10-17 | 2025-10-16 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Exer. | 318,282 | $5.04M | +130.2% | open → |
| 2025-10-17 | 2025-10-15 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Sale | 414,683 | $7.02M | +115.5% | open → |
| 2025-10-17 | 2025-10-15 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Exer. | 414,683 | $6.57M | +130.2% | open → |
| 2025-10-14 | 2025-10-13 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Sale | 20,727 | $336.8K | +124.6% | open → |
| 2025-10-14 | 2025-10-13 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Exer. | 20,727 | $328.5K | +130.2% | open → |
| 2025-10-14 | 2025-10-09 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Sale | 104,940 | $1.71M | +123.9% | open → |
| 2025-10-14 | 2025-10-09 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Exer. | 104,940 | $1.66M | +130.2% | open → |
| 2025-10-08 | 2025-10-08 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Sale | 138,602 | $2.25M | +125.2% | open → |
| 2025-10-08 | 2025-10-08 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Exer. | 128,295 | $955.8K | +389.8% | open → |
| 2025-10-08 | 2025-10-08 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Exer. | 10,307 | $163.4K | +130.2% | open → |
| 2025-10-08 | 2025-10-07 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Sale | 355,161 | $5.74M | +125.9% | open → |
| 2025-10-08 | 2025-10-07 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Exer. | 180,859 | $696.3K | +847.8% | open → |
| 2025-10-08 | 2025-10-07 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Exer. | 107,131 | $798.1K | +389.8% | open → |
| 2025-10-08 | 2025-10-07 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Exer. | 67,171 | $1.06M | +130.2% | open → |
| 2025-10-08 | 2025-10-06 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Sale | 171,396 | $2.80M | +123.3% | open → |
| 2025-10-08 | 2025-10-06 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Exer. | 19,141 | $73.7K | +847.8% | open → |
| 2025-10-08 | 2025-10-06 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Exer. | 24,900 | $185.5K | +389.8% | open → |
| 2025-10-08 | 2025-10-06 | ROIV Roivant Sciences Ltd. | President & Immunovant CEO | Exer. | 127,355 | $2.02M | +130.2% | open → |
| 2025-07-23 | 2025-07-21 | ROIV Roivant Sciences Ltd. | Officer President & Immunovant CEO | Exer. | 100,000 | $385.0K | +847.8% | open → |
| 2025-07-23 | 2025-07-21 | ROIV Roivant Sciences Ltd. | Officer President & Immunovant CEO | Sale | 100,000 | $1.15M | +216.8% | open → |
| 2025-08-01 | 2025-07-30 | ROIV Roivant Sciences Ltd. | Officer President & Immunovant CEO | Grant | 198,413 | $0.00 | — | open → |
| 2025-08-22 | 2025-08-20 | ROIV Roivant Sciences Ltd. | Officer President & Immunovant CEO | Tax | 7,051 | $82.6K | +211.3% | open → |
| 2025-08-22 | 2025-08-20 | ROIV Roivant Sciences Ltd. | Officer President & Immunovant CEO | Sale | 100,000 | $1.17M | +211.3% | open → |
| 2025-08-22 | 2025-08-20 | ROIV Roivant Sciences Ltd. | Officer President & Immunovant CEO | Exer. | 100,000 | $385.0K | +847.8% | open → |
| 2025-09-23 | 2025-09-22 | ROIV Roivant Sciences Ltd. | Officer President & Immunovant CEO | Sale | 100,000 | $1.50M | +143.1% | open → |
| 2025-09-23 | 2025-09-22 | ROIV Roivant Sciences Ltd. | Officer President & Immunovant CEO | Sale | 316,182 | $4.74M | +143.4% | open → |
| 2025-09-23 | 2025-09-22 | ROIV Roivant Sciences Ltd. | Officer President & Immunovant CEO | Exer. | 100,000 | $385.0K | +847.8% | open → |
| 2025-09-23 | 2025-09-22 | ROIV Roivant Sciences Ltd. | Officer President & Immunovant CEO | Exer. | 462,374 | $1.78M | +847.8% | open → |
| 2025-09-23 | 2025-09-23 | ROIV Roivant Sciences Ltd. | Officer President & Immunovant CEO | Sale | 611,000 | $9.06M | +146.1% | open → |
| 2025-09-23 | 2025-09-19 | ROIV Roivant Sciences Ltd. | Officer President & Immunovant CEO | Sale | 683,818 | $10.22M | +144.1% | open → |
| 2025-09-23 | 2025-09-19 | ROIV Roivant Sciences Ltd. | Officer President & Immunovant CEO | Exer. | 1,000,000 | $3.85M | +847.8% | open → |
